Alison E. Mackie

727 total citations
34 papers, 571 citations indexed

About

Alison E. Mackie is a scholar working on Plant Science, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Alison E. Mackie has authored 34 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Plant Science, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Physiology. Recurrent topics in Alison E. Mackie's work include Inhalation and Respiratory Drug Delivery (8 papers), Asthma and respiratory diseases (8 papers) and Plant Disease Resistance and Genetics (5 papers). Alison E. Mackie is often cited by papers focused on Inhalation and Respiratory Drug Delivery (8 papers), Asthma and respiratory diseases (8 papers) and Plant Disease Resistance and Genetics (5 papers). Alison E. Mackie collaborates with scholars based in United Kingdom, Australia and United States. Alison E. Mackie's co-authors include Alan Bye, Christine Falcoz, G P Ventresca, Richard A. Jones, Hartmut Derendorf, Shashank Rohatagi, Simon McKirdy, Richard W. Fuller, J. C. Slaughter and B. A. Coutts and has published in prestigious journals such as Nature Communications, Pharmaceutical Research and Clinical Pharmacokinetics.

In The Last Decade

Alison E. Mackie

34 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison E. Mackie United Kingdom 14 220 218 145 71 63 34 571
Siva Kumar Solleti India 15 78 0.4× 199 0.9× 166 1.1× 295 4.2× 20 0.3× 20 666
Jisun Jung South Korea 11 129 0.6× 23 0.1× 23 0.2× 381 5.4× 57 0.9× 15 843
Carine Delayre‐Orthez France 13 188 0.9× 61 0.3× 16 0.1× 228 3.2× 73 1.2× 24 625
Yuanli Chen China 13 79 0.4× 39 0.2× 125 0.9× 239 3.4× 4 0.1× 24 662
Ying Fu China 12 121 0.6× 39 0.2× 113 0.8× 399 5.6× 3 0.0× 16 666
Luiz Henrique Agra Cavalcante‐Silva Brazil 16 75 0.3× 41 0.2× 106 0.7× 222 3.1× 21 0.3× 43 688
N. M. KHANNA India 14 165 0.8× 80 0.4× 96 0.7× 212 3.0× 22 0.3× 31 664
Hyuck Kim South Korea 17 56 0.3× 24 0.1× 54 0.4× 385 5.4× 5 0.1× 55 827
Yaqi Meng China 14 107 0.5× 199 0.9× 41 0.3× 238 3.4× 11 0.2× 27 574
B Behnke Germany 15 63 0.3× 26 0.1× 96 0.7× 338 4.8× 10 0.2× 27 793

Countries citing papers authored by Alison E. Mackie

Since Specialization
Citations

This map shows the geographic impact of Alison E. Mackie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison E. Mackie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison E. Mackie more than expected).

Fields of papers citing papers by Alison E. Mackie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison E. Mackie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison E. Mackie. The network helps show where Alison E. Mackie may publish in the future.

Co-authorship network of co-authors of Alison E. Mackie

This figure shows the co-authorship network connecting the top 25 collaborators of Alison E. Mackie. A scholar is included among the top collaborators of Alison E. Mackie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison E. Mackie. Alison E. Mackie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newsome, Philip N., Arun J. Sanyal, Guy Neff, et al.. (2023). A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis. Nature Communications. 14(1). 7151–7151. 10 indexed citations
2.
Mackie, Alison E., et al.. (2020). First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers. ERJ Open Research. 7(1). 447–2020. 7 indexed citations
3.
Mackie, Alison E., Brendan Rodoni, Martin J. Barbetti, Simon McKirdy, & Richard A. Jones. (2016). Potato spindle tuber viroid: alternative host reservoirs and strain found in a remote subtropical irrigation area. European Journal of Plant Pathology. 145(2). 433–446. 16 indexed citations
4.
5.
Mackie, Alison E., et al.. (2011). BRIEF COMMUNICATION: The effects of different forage types on lamb performance and meat quality. Proceedings of the New Zealand Society of Animal Production. 71. 208–210. 8 indexed citations
6.
Davison, E. M., A. Drenth, Sanjay Kumar, et al.. (2006). Pathogens associated with nursery plants imported into Western Australia. Australasian Plant Pathology. 35(4). 473–473. 30 indexed citations
7.
Thalamas, Claire, Iris Rajman, Jaime Kulisevsky, et al.. (2005). Pergolide. Clinical Neuropharmacology. 28(3). 120–125. 12 indexed citations
8.
Sharma, Shivali, Simon McKirdy, Alison E. Mackie, & F. Lamberti. (2003). First record of Xiphinema rivesi associated with grape vines in Western Australia. Nematologia mediterranea. 31(1). 2 indexed citations
9.
McKirdy, Simon, et al.. (2002). . Australasian Plant Pathology. 31(1). 97–97. 2 indexed citations
10.
Mackie, Alison E. & J. C. Slaughter. (2002). Formation of 4-Hydroxyfuranones and their Precursors during Production of Worts and Beers. Journal of the Institute of Brewing. 108(3). 336–343. 9 indexed citations
11.
Mackie, Alison E., et al.. (2000). Systemic Exposure to Fluticasone Propionate Administered via Metered-Dose Inhaler Containing Chlorofluorocarbon or Hydrofluoroalkane Propellant. Clinical Pharmacokinetics. 39(Supplement 1). 17–22. 28 indexed citations
12.
Brindley, C., Christine Falcoz, Alison E. Mackie, & Alan Bye. (2000). Absorption Kinetics after Inhalation of Fluticasone Propionate via the Diskhaler??, Diskus?? and Metered-Dose Inhaler in Healthy Volunteers. Clinical Pharmacokinetics. 39(Supplement 1). 1–8. 25 indexed citations
13.
Mackie, Alison E. & Alan Bye. (2000). The Relationship between Systemic Exposure to Fluticasone Propionate and Cortisol Reduction in Healthy Male Volunteers. Clinical Pharmacokinetics. 39(Supplement 1). 47–54. 14 indexed citations
14.
Falcoz, Christine, John Horton, Alison E. Mackie, Stuart M. Harding, & Peter T. Daley‐Yates. (2000). Pharmacokinetics of Fluticasone Propionate Inhaled via the Diskhaler?? and Diskus?? Powder Devices in Patients with Mild-to-Moderate Asthma. Clinical Pharmacokinetics. 39(Supplement 1). 31–37. 19 indexed citations
15.
Mackie, Alison E., et al.. (2000). Pharmacokinetics of Fluticasone Propionate Inhaled via the Diskhaler?? and Diskus?? Powder Devices in Healthy Volunteers. Clinical Pharmacokinetics. 39(Supplement 1). 23–30. 34 indexed citations
16.
Mackie, Alison E. & J. C. Slaughter. (2000). Key Steps during Barley Malting That Influence the Concentration of Flavor Compounds. Journal of the American Society of Brewing Chemists. 58(2). 69–72. 13 indexed citations
17.
Rohatagi, Shashank, Alan Bye, Christine Falcoz, et al.. (1996). Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate. The Journal of Clinical Pharmacology. 36(10). 938–941. 46 indexed citations
18.
Rohatagi, Shashank, Alan Bye, Alison E. Mackie, & Hartmut Derendorf. (1996). Mathematical modeling of cortisol circadian rhythm and cortisol suppression. European Journal of Pharmaceutical Sciences. 4(6). 341–350. 40 indexed citations
19.
Mackie, Alison E., G P Ventresca, Richard W. Fuller, & Alan Bye. (1996). Pharmacokinetics of intravenous fluticasone propionate in healthy subjects. British Journal of Clinical Pharmacology. 41(6). 539–542. 67 indexed citations
20.
Mackie, Alison E., et al.. (1988). Glucocorticoids and the cell surface of human glioma cells: relationship to cytostasis.. PubMed. 9. 101–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siva Kumar Solleti Breakdown of academic impact, for papers by Jisun Jung Breakdown of academic impact, for papers by Carine Delayre‐Orthez Breakdown of academic impact, for papers by Yuanli Chen Breakdown of academic impact, for papers by Ying Fu Breakdown of academic impact, for papers by Luiz Henrique Agra Cavalcante‐Silva Breakdown of academic impact, for papers by N. M. KHANNA Breakdown of academic impact, for papers by Hyuck Kim Breakdown of academic impact, for papers by Yaqi Meng Breakdown of academic impact, for papers by B Behnke
Rankless by CCL
2026